Already a member? Click here to login.
Already a member? Click here to login.
ADEA is working with JDRF and other stakeholders to advocate for CDEs and diabetes educators to ensure they receive the best possible information, education, training, and access to the Federal Government’s Insulin Pump Program following a decision to change the program.
Administered by JDRF Australia, the program provides insulin pumps to Australians living with type 1 diabetes, up to the age of 21, who meet certain financial and clinical eligibility requirements.
Earlier this year, the Department of Health reviewed the products offered in the program.
Diabetes organisations provided feedback to the department as part of this review.
JDRF Australia understands the importance of choices in diabetes management technology, which was detailed in its response, to people in the type 1 diabetes community.
ADEA shares the same view as JDRF regarding choices in diabetes management technology.
After its review, the department has decided that insulin pumps manufactured by a single supplier, Ypsomed, will be available through the program.
These include the recently launched mylife YpsoPump with CamAPS FX.
The pump can be combined with the mylife CamAPS FX mobile application and the Dexcom G6 Continuous Glucose Monitoring (CGM) System for an automated insulin delivery system managed directly on Android devices.
JDRF Australia is working with Yposmed on the required arrangements to begin distributing pumps through the program as quickly as possible.
ADEA knows you will have questions about the new arrangements as we do.
JDRF and we will endeavour to keep you updated and provide answers as they become available during this transition.
If you want to learn more about the pump, please contact Ypsomed at 1800 447 042 or info@ypsomed.com.au.
If you have a query about an application you have been working on, please contact pumps@jdrf.org.au.
ADEA is working with JDRF and other stakeholders to advocate for CDEs and diabetes educators to ensure they receive the best possible information, education, training, and access to the Federal Government’s Insulin Pump Program following a decision to change the program.
Administered by JDRF Australia, the program provides insulin pumps to Australians living with type 1 diabetes, up to the age of 21, who meet certain financial and clinical eligibility requirements.
Earlier this year, the Department of Health reviewed the products offered in the program.
Diabetes organisations provided feedback to the department as part of this review.
JDRF Australia understands the importance of choices in diabetes management technology, which was detailed in its response, to people in the type 1 diabetes community.
ADEA shares the same view as JDRF regarding choices in diabetes management technology.
After its review, the department has decided that insulin pumps manufactured by a single supplier, Ypsomed, will be available through the program.
These include the recently launched mylife YpsoPump with CamAPS FX.
The pump can be combined with the mylife CamAPS FX mobile application and the Dexcom G6 Continuous Glucose Monitoring (CGM) System for an automated insulin delivery system managed directly on Android devices.
JDRF Australia is working with Yposmed on the required arrangements to begin distributing pumps through the program as quickly as possible.
ADEA knows you will have questions about the new arrangements as we do.
JDRF and we will endeavour to keep you updated and provide answers as they become available during this transition.
If you want to learn more about the pump, please contact Ypsomed at 1800 447 042 or info@ypsomed.com.au.
If you have a query about an application you have been working on, please contact pumps@jdrf.org.au.
